Genome-wide association studies (GWAS) have found BRINP1 to be associated with neurological disorders: BRINP1 (DBC1) variation is reported as a potential biomarker that discriminates with first episode schizophrenia [30]; BRINP1 SNPs show association with Parkinson’s disease [31, 32], as well as with late-onset dementia [33]. The gene discussed is BRINP1; the disease is schizophrenia.